CCR2 and hepatocellular carcinoma: Recent evidence shows that miR206 can promote the expression of CCL2 by inhibiting KLF4 in M1 macrophages, a subtype of Kupffer cells, to increase the level of CCR2+ cytotoxic T cells, thereby inhibiting the occurrence and development of HCC (61).